RFL (Rafael Holdings) Short Interest


RFL Rafael Holdings Inc RFL
48 GF Score
Price $2.70
GF Value $1.35
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Rafael Holdings Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

RFL vs ASPS, MAYS, EUDA: Short Interest Comparison

For the Real Estate Services subindustry, Rafael Holdings's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rafael Holdings Short Interest vs Real Estate Industry

For the Real Estate industry and Real Estate sector, Rafael Holdings's Short Interest distribution charts can be found below:

* The bar in red indicates where Rafael Holdings's Short Interest falls into.


RFL
48GF Score
Rafael Holdings Inc RFL
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Rafael Holdings (RFL) Overvalued in 2026?

Based on GuruFocus' analysis, Rafael Holdings stock appears to be overvalued. The current stock price of $2.70 is trading 100% above its estimated GF Value™ of $1.35. GuruFocus considers Rafael Holdings to be Significantly Overvalued.

Key valuation signals for RFL:

  • Short Interest:
  • GF Value™: $1.35 vs. price of $2.70 (100% above fair value)
  • GF Score™: 48/100 with 8 warning signs

No single metric tells the full story. See the RFL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rafael Holdings Business Description

Address 520 Broad Street, Newark, NJ, USA, 07102
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.
48GF Score

Get the complete analysis for RFL

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.70
Price
$1.35
GF Value